Guonian N. Wang

No. 150 Haping Rd
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

CB2 receptor agonist AM1241 regulating the polarization of microglia reduces morphine tolerance through IL-4/STAT6 pathway.

CB2 receptor agonist AM1241 regulating the polarization of microglia reduces morphine tolerance through IL-4/STAT6 pathway.

Journal: Molecular pain
Published: August 18, 2025

Efficacy and safety of SHR8554 on postoperative pain in subjects with moderate to severe acute pain following orthopedic surgery: A multicenter, randomized, double-blind, dose-explored, active-controlled, phase II/III clinical trial.

Efficacy and safety of SHR8554 on postoperative pain in subjects with moderate to severe acute pain following orthopedic surgery: A multicenter, randomized, double-blind, dose-explored, active-controlled, phase II/III clinical trial.

Journal: Pharmacological research
Published: November 04, 2024

Current state and future education implication of enhanced recovery after surgery (ERAS) among Chinese anesthesiologists: national repeated cross-sectional surveys from 2019 to 2023.

Current state and future education implication of enhanced recovery after surgery (ERAS) among Chinese anesthesiologists: national repeated cross-sectional surveys from 2019 to 2023.

Journal: BMC medical education
Published: September 30, 2024

Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial.

Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial.

Journal: JAMA dermatology
Published: September 25, 2024

The IL-1β/STAT1 Axis inhibits STAT3 function via Sequestration of the transcriptional activator GLIS2, leading to postoperative vascular dysfunction.

The IL-1β/STAT1 Axis inhibits STAT3 function via Sequestration of the transcriptional activator GLIS2, leading to postoperative vascular dysfunction.

Journal: International immunopharmacology
Published: August 16, 2024

HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials.

HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials.

Journal: Nature communications
Published: July 19, 2024

Exercise-conditioned plasma ameliorates postoperative cognitive dysfunction by activating hippocampal cholinergic circuit and enhancing BDNF/TrkB signaling.

Exercise-conditioned plasma ameliorates postoperative cognitive dysfunction by activating hippocampal cholinergic circuit and enhancing BDNF/TrkB signaling.

Journal: Cell communication and signaling : CCS
Published: June 18, 2024

Involvement of CXCL12/CXCR4 in CB2 receptor agonist-attenuated morphine tolerance in Walker 256 tumor-bearing rats with cancer pain.

Involvement of CXCL12/CXCR4 in CB2 receptor agonist-attenuated morphine tolerance in Walker 256 tumor-bearing rats with cancer pain.

Journal: European journal of medical research
Published: May 16, 2024

The immune regulation and therapeutic potential of the SMAD gene family in breast cancer.

The immune regulation and therapeutic potential of the SMAD gene family in breast cancer.

Journal: Scientific reports
Published: August 28, 2023

PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer.

PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer.

Journal: Breast cancer (Dove Medical Press)
Published: August 18, 2023

Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway.

Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway.

Journal: Immunopharmacology and immunotoxicology
Published: June 26, 2023

Dexmedetomidine promotes necroptosis by upregulating PARP1 in non-small cell lung cancer.

Dexmedetomidine promotes necroptosis by upregulating PARP1 in non-small cell lung cancer.

Journal: Biotechnology & genetic engineering reviews
Published: April 17, 2023
Showing 1-12 of 53

Last Updated: 09/26/2026